Small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung Cancer [Phase 2]
This update notes that the Phase 2, open-label study of amuvatinib with platinum-etoposide chemotherapy in small cell lung cancer has comple…
-
CLINICAL_TRIALS trial_result · 2024-07-30Clinical Trial Update: A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors [Phase 2]
A Phase 2 trial evaluating Cediranib in combination with Olaparib in advanced solid tumors has posted results as of 2024-07-30. Indications …
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Study of Low-Dose Radiotherapy (LDRT) Concurrent Cisplatin/Carboplatin Plus Etoposide With Atezolizumab for Patients With Extensive-Stage Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating low-dose radiotherapy with cisplatin/carboplatin, etoposide, and atezolizumab in extensive-stage small cell lung …
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer
A study evaluating durvalumab (Imfinzi) in patients with extensive-stage small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: A Study of Atezolizumab in Combination With Carboplatin Plus Etoposide to Investigate Safety and Efficacy in Patients With Untreated Extensive-Stage Small Cell Lung Cancer [Phase 3]
Phase 3 trial evaluating atezolizumab with carboplatin and etoposide for untreated extensive-stage small cell lung cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating Chiauranib in patients with small cell lung cancer and advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-15Clinical Trial Update: Mass Balance Study of [14C]Chiauranib [NA]
The mass balance pharmacokinetic study of [14C]Chiauranib has completed for Small cell lung cancer, as reported by Chipscreen Biosciences.
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Phase 3 Study Evaluating Efficacy, Safety and Pharmacokinetics of Trilaciclib In Small Cell Lung Cancer Patients [Phase 3]
Phase 3 trial evaluating trilaciclib for efficacy, safety, and pharmacokinetics in extensive-stage small cell lung cancer has completed and …
-
CLINICAL_TRIALS trial_result · 2024-07-10Clinical Trial Update: Study of Irinotecan Liposome Injection as Second-line Regimen in Patients With Small Cell Lung Cancer (SCLC) [Phase 2]
Phase 2 study evaluating irinotecan liposome injection as a second-line regimen for small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-07-05Clinical Trial Update: Efficacy and Safety Study of a New Therapeutic Strategy in the Treatment of Extended-Disease Small-Cell Lung Cancer [Phase 2]
This update reports the completion of a Phase 2 efficacy and safety study evaluating a new therapeutic strategy for extended-disease small c…
-
CLINICAL_TRIALS trial_result · 2024-06-28Clinical Trial Update: Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases [Phase 2]
Phase 2 clinical trial update evaluating the combination of radiosurgery and nivolumab for brain metastases in various cancers, with complet…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Whole-Brain Radiation Therapy With or Without Hippocampal Avoidance in Limited Stage or Extensive Stage Small Cell Lung Cancer [Phase 2, Phase 3]
A phase 2/3 trial evaluated whole-brain radiation therapy with or without hippocampal avoidance in patients with limited-stage or extensive-…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer [Phase 2]
Phase 2 randomized trial comparing aldoxorubicin to topotecan in metastatic small cell lung cancer; results assess efficacy and safety.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of carfilzomib with irinotecan in irinotecan-sensitive cancers and small cell lung cancer has com…
-
CLINICAL_TRIALS trial_result · 2024-05-08Clinical Trial Update: eRAPID: Online Symptom Reporting in Lung Cancer [NA]
The eRAPID online symptom reporting study in thoracic cancers has completed, including non-small cell lung cancer, small-cell lung cancer, a…
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated tinengotinib (TT-00420) as a monotherapy and in combination therapy for patients with advanced solid tu…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Irinotecan Hydrochloride Liposome Injection (LY01610) For Small Cell Lung Cancer [Phase 2]
Phase 2 trial of Irinotecan hydrochloride liposome injection (LY01610) for Small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: Two-Part, Open-Label, Multi-Center, Phase 1/2 Study of BIW-8962 as Monotherapy in Subjects With Lung Cancer [Phase 1, Phase 2]
A two-part Phase 1/2 trial of BIW-8962 as monotherapy in lung cancer has been terminated; the study evaluated Non-Small Cell Lung Cancer, Sm…
-
CLINICAL_TRIALS trial_result · 2024-04-25Clinical Trial Update: SNC115 Injections in Patients With Recurrent/Refractory Small Cell Lung Cancer and Lung Large Cell Neuroendocrine Carcinoma [Phase 1]
Phase 1 clinical trial of SNC115 injections for patients with recurrent/refractory small cell lung cancer and large cell neuroendocrine carc…
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: Study of LY01610 in Patients With Recurrent Small Cell Lung Cancer [Phase 3]
A Phase 3 clinical trial is ongoing to evaluate LY01610 in patients with relapsed small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2024-03-13Clinical Trial Update: Chemotherapy and Atezolizumab for Patients With Extensive Stage Small Cell Lung Cancer (SCLC) With Untreated, Asymptomatic Brain Metastases [Phase 2]
A Phase 2 trial investigating chemotherapy plus atezolizumab for extensive-stage small cell lung cancer with untreated asymptomatic brain me…
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: BMS-986012 in Relapsed/Refractory SCLC [Phase 1, Phase 2]
Phase 1/2 trial updates for BMS-986012 in relapsed/refractory small cell lung cancer are completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: FR901228 in Treating Patients With Refractory or Progressive Small Cell Lung Cancer or Non-small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial of FR901228 in patients with refractory or progressive small cell lung cancer or non-small cell lung cancer has compl…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: A Phase IIII Study of AL8326 in Small Cell Lung Cancer [Phase 3]
A Phase III trial update for AL8326 in small cell lung cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-01-17Clinical Trial Update: Prospective Clinicogenomic Program [Phase 4]
A Phase 4 prospective clinicogenomic program in progress for non-small cell lung cancer and small-cell lung cancer has completed.